Procter & Gamble Beats Q4 2026 EPS Estimate but Falls Short on Revenue as Stock Holds Steady
By TrendSpider Editor
Procter & Gamble reported Q4 2026 earnings before the market opened this morning, delivering a mixed result that left shares nearly unchanged at $146.04, down just 0.08% on the session. The company posted EPS of $1.43, edging past the $1.42 estimate by 0.7%, but revenue of $21.20 billion came in 1.1
Procter & Gamble Beats Q4 2026 EPS Estimate but Falls Short on Revenue as Stock Holds Steady
Procter & Gamble reported Q4 2026 earnings before the market opened this morning, delivering a mixed result that left shares nearly unchanged at $146.04, down just 0.08% on the session. The company posted EPS of $1.43, edging past the $1.42 estimate by 0.7%, but revenue of $21.20 billion came in 1.1% below the consensus estimate of $21.44 billion. With PG trading well off its 52-week high of $167.24 and closer to its 52-week low of $137.62, today's report does little on its own to shift the stock's broader trajectory.
Key Drivers of the PG Stock Move
- Main Catalyst: PG reported Q4 2026 EPS of $1.43, a 0.7% beat against the $1.42 estimate, but revenue of $21.20 billion missed expectations by 1.1%, coming in below the $21.44 billion estimate. Earnings declined 3.38% year over year while revenue grew just 1.5%.
- Bull Case: The EPS beat, even if narrow at $0.01 above the estimate, demonstrates that PG continues to manage its cost structure effectively. Revenue growth of 1.5% signals the business is still expanding, and the bottom-line resilience in a challenging consumer environment may reassure income-oriented investors.
- Bear Case: The 1.1% revenue miss against a $21.44 billion estimate, paired with a 3.38% year-over-year decline in earnings, points to real pressure on PG's top and bottom lines. With the stock already sitting roughly 12.7% below its 52-week high, a soft revenue result gives bulls little new ammunition to push shares meaningfully higher.
The forward setup for PG remains cautious. A modest EPS beat is unlikely to be enough to reverse the stock's underperformance relative to its 52-week high when earnings growth is contracting on an annual basis. Consumer staples companies like PG are navigating a difficult environment of slowing volume growth and ongoing pressure from private-label competition. While PG's pricing power has historically supported margins, the revenue miss this quarter suggests organic volume or pricing gains may be losing steam. Investors will be watching management's guidance commentary closely for any signals on whether the second half of fiscal 2027 could deliver a return to stronger top-line growth.
PG Seasonality
Q4 earnings results reported in late July have historically marked a reset point for consumer staples stocks heading into the back-to-school and fall restocking period, which can provide a modest seasonal tailwind for household products demand. However, PG's mixed Q4 2026 print may limit any near-term seasonal lift if revenue trends do not show improvement in the coming quarter.
PG Relative Performance
At $146.04, PG is trading roughly 12.7% below its 52-week high of $167.24 and approximately 6.1% above its 52-week low of $137.62, placing the stock in the lower half of its annual range. The near-flat price reaction of negative 0.08% following a mixed earnings report suggests the market had already tempered expectations, but the lack of a meaningful bounce on an EPS beat reflects lingering concern about the revenue trajectory and the 3.38% year-over-year earnings decline.
More on PG
- Procter & Gamble Tops Q1 2027 Earnings Estimates, Shares Surge Toward 52-Week High
- Procter & Gamble Tops Q1 2027 Earnings Estimates With a 5.82% EPS Surprise, Shares Surge to Near 52-Week Highs
- Procter & Gamble Surges 5.54% to Near 52-Week High as Shares Break Out
- Procter & Gamble Surges 5.54% in a Single Session, Pushing Shares to Within Striking Distance of 52-Week High
- Procter & Gamble Surges 5.54%, Closing In on 52-Week High at $165.58
Latest Market News
- Mastercard Beats Q3 2026 EPS and Revenue Estimates as Earnings Surge 21%
- Eli Lilly Crushes Q3 2026 Estimates With 17.6% EPS Surprise, Stock Breaks to New 52-Week High
- Philip Morris International Hovers Near 52-Week High as Shares Approach $210.44 Peak
- Amazon Misses Q3 2026 EPS and Revenue Estimates, Shares Slide After the Bell
- NVDA Stock Slides Nearly 6% Friday, Falling to Its Lowest Level in Months
- Berkshire Hathaway Hovers Near 52-Week Peak as BRK.B Climbs Toward $549.94 Resistance